Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo

Published:2021-11 Issue:6 Volume:16 Page:762-771
ISSN:1818-0876
Container-title:Asian Journal of Pharmaceutical Sciences
language:en
Short-container-title:Asian Journal of Pharmaceutical Sciences

Author:

Yang Lu,Xu Jiaxi,Xie Zheng,Song Faquan,Wang Xin,Tang Rupei^ORCID

Funder

Scientific Research Foundation of Education Department of Anhui Province of China

National Natural Science Foundation of China

Anhui University

Natural Science Foundation of Anhui Province

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference44 articles.

1. Self-delivery nanoparticles of an amphiphilic irinotecan-enediyne conjugate for cancer combination chemotherapy;Li;J Mater Chem B,2019

2. Prodrugs-from serendipity to rational design;Huttunen;Pharmacol Rev,2011

3. Drug self-delivery systems for cancer therapy;Qin;Biomaterials,2017

4. Self-assembling nanoparticles of dually hydrophobic prodrugs constructed from camptothecin analogue for cancer therapy;Zhang;Eur J Med Chem,2020

5. Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy;Zhou;Nat Nanotechnol,2019

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isoalantolactone/hydroxamic acid hybrids as potent dual STAT3/HDAC inhibitors and self-assembled nanoparticles for cancer therapy;European Journal of Medicinal Chemistry;2024-11

2. FABRICATION, OPTIMIZATION AND IN VITRO CYTOTOXICITY EVALUATION OF DASATINIB MONOHYDRATE-LOADED NANOPARTICLES;International Journal of Applied Pharmaceutics;2024-09-07

3. Co-assembly of cisplatin and dasatinib in hyaluronan nanogel to combat triple negative breast cancer with reduced side effects;International Journal of Biological Macromolecules;2024-06

4. pH-responsive self-assembled nanoparticles for tumor-targeted drug delivery;Journal of Drug Targeting;2024-05-09

5. Cisplatin-Based Combination Therapy for Enhanced Cancer Treatment;Current Drug Targets;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3